Altimmune, Inc. (ALT) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts ALT Hot Sheet
Join SI Premium – FREE
Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.32), $0.15 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leerink Starts Altimmune (ALT) at Outperform
- Energy Fuels to acquire rare earth magnet maker VAC for $1.9 billion
- RBC Capital Starts Molina Healthcare (MOH) at Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
